GSK and Lyell Partner on Cancer Therapies

14.10.2019 - Major UK drugmaker GlaxoSmithKline (GSK) has announced a five-year collaboration with US biotech Lyell Immunopharma to develop new technologies to improve cell therapies for cancer...